News
Medscape
July 26, 2023
A growing body of work has prompted researchers and drug developers to take a look at how genetics influence Parkinson’s risk and progression. PD GENEration, the genetics study from the Parkinson’s Foundation, is building the largest genetic data bank of sequenced sets of PD-risk genes made accessible to patients. Featured interviews include James Beck, PhD, SVP and chief scientific officer at the Parkinson’s Foundation; Roy N. Alcalay, MD, MS, PD GENEration principal investigator, and Kathleen E. McKee, MD, PD GENEration principal investigator at Intermountain Health.